Indrayani Biotech Ltd Stock Price Today (NSE: INDRANIB)
Fundamental Score
Indrayani Biotech Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Indrayani Biotech Ltd share price today is ₹8.42, up +0.00% on NSE/BSE as of 17 February 2026. Indrayani Biotech Ltd (INDRANIB) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of ₹68.07 (Cr). The 52-week high for INDRANIB share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -8.75% and a debt-to-equity ratio of 1.89.
Indrayani Biotech Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Indrayani Biotech Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Indrayani Biotech Share Price: A Fundamental Audit Perspective
The agricultural sector focusing on other agricultural products often benefits from specialized solutions that cater to niche markets and local farming needs. In this context, we examine the Indrayani Biotech share price, currently at ₹8.22, as part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra. This analysis aims to provide an objective assessment of the company's financial standing based on available data and publicly accessible information.
A key metric to consider is the Return on Capital Employed (ROCE). Indrayani Biotech Ltd presents a concerning ROCE of -1.12%. A negative ROCE suggests the company is not efficiently generating profits from its capital investments. This directly impacts the company's economic moat, weakening its ability to sustain competitive advantages and potentially hindering future growth prospects. Unlike companies with robust ROCE figures, Indrayani Biotech’s negative value indicates operational inefficiencies that require careful scrutiny.
When considering peer performance, comparing Indrayani Biotech with companies like
Kaveri Seed Company Limited highlights potential disparities in management quality and operational effectiveness. While this analysis doesn't offer an exhaustive evaluation of management, the stark difference in ROCE, assuming peers have positive figures, may reflect varying levels of managerial competency in capital allocation and strategic decision-making. It is crucial to assess not only the financials but also the qualitative aspects of the business to understand long-term sustainability. Publicly available information on Kaveri Seed Company Limited indicates higher management quality.The absence of a Price-to-Earnings (PE) ratio for Indrayani Biotech Ltd further complicates the analysis, potentially signaling a lack of profitability or insufficient earnings to calculate this key valuation metric. This lack of PE requires further investigation to determine the underlying causes and assess the company's earnings potential. This analysis relies solely on observable facts and financial ratios. This serves an informational purpose only and should not be construed as investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Indrayani Biotech Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of INDRANIB across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Consistent Growth Track Record (21.21% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Risk Factors
9 factors identified
Below-Average Return on Equity (-8.75%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-1.12%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-81.18%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-7.71%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Elevated Debt Levels (D/E: 1.89)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (-3.07x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-52.50 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 3.13%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Indrayani Biotech Ltd Financial Statements
Comprehensive financial data for Indrayani Biotech Ltd including income statement, balance sheet and cash flow
About INDRANIB (Indrayani Biotech Ltd)
Indrayani Biotech Ltd (INDRANIB) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Other Agricultural Products sector with a current market capitalisation of ₹68.07 (Cr). Indrayani Biotech Ltd has delivered a Return on Equity (ROE) of -8.75% and a ROCE of -1.12%. The debt-to-equity ratio stands at 1.89, reflecting the company's capital structure. Investors tracking INDRANIB share price can monitor key metrics including P/E ratio, promoter holding of 33.26%, and quarterly earnings growth.
Company Details
Key Leadership
INDRANIB Share Price: Frequently Asked Questions
What is the current share price of Indrayani Biotech Ltd (INDRANIB)?
As of 17 Feb 2026, 10:11 am IST, Indrayani Biotech Ltd share price is ₹8.42. The INDRANIB stock has a market capitalisation of ₹68.07 (Cr) on NSE/BSE.
Is INDRANIB share price Overvalued or Undervalued?
INDRANIB share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 21.07x. Based on this relative valuation, the Indrayani Biotech Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of INDRANIB share price?
The 52-week high of INDRANIB share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Indrayani Biotech Ltd share price?
Key factors influencing INDRANIB share price include quarterly earnings growth (Sales Growth: -7.71%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Indrayani Biotech Ltd a good stock for long-term investment?
Indrayani Biotech Ltd shows a 5-year Profit Growth of N/A% and an ROE of -8.75%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.89 before investing in INDRANIB shares.
How does Indrayani Biotech Ltd compare with its industry peers?
Indrayani Biotech Ltd competes with major peers in the Other Agricultural Products. Investors should compare INDRANIB share price P/E of 0.00x and ROE of -8.75% against the industry averages to determine competitive standing.
What is the P/E ratio of INDRANIB and what does it mean?
INDRANIB share price has a P/E ratio of N/Ax compared to the industry average of 21.07x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is INDRANIB performing according to Bull Run's analysis?
INDRANIB has a Bull Run fundamental score of 2.6/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does INDRANIB belong to?
INDRANIB operates in the Other Agricultural Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Indrayani Biotech Ltd share price.
What is Return on Equity (ROE) and why is it important for INDRANIB?
INDRANIB has an ROE of -8.75%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Indrayani Biotech Ltd generates profits from shareholders capital.
How is INDRANIB debt-to-equity ratio and what does it indicate?
INDRANIB has a debt-to-equity ratio of 1.89, which indicates high leverage that increases financial risk.
What is INDRANIB dividend yield and is it a good dividend stock?
INDRANIB offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Indrayani Biotech Ltd shares.
How has INDRANIB share price grown over the past 5 years?
INDRANIB has achieved 5-year growth rates of: Sales Growth 21.21%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in INDRANIB and why does it matter?
Promoters hold 33.26% of INDRANIB shares, with 2.46% pledged. High promoter holding often indicates strong management confidence in Indrayani Biotech Ltd.
What is INDRANIB market capitalisation category?
INDRANIB has a market capitalisation of ₹68 crores, placing it in the Small-cap category.
How volatile is INDRANIB stock?
INDRANIB has a beta of N/A. A beta > 1 suggests the Indrayani Biotech Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is INDRANIB operating profit margin trend?
INDRANIB has a 5-year average Operating Profit Margin (OPM) of 10.74%, indicating the company's operational efficiency.
How is INDRANIB quarterly performance?
Recent quarterly performance shows Indrayani Biotech Ltd YoY Sales Growth of -7.71% and YoY Profit Growth of -81.18%.
What is the institutional holding pattern in INDRANIB?
INDRANIB has FII holding of 0.00% and DII holding of 3.13%. Significant institutional holding often suggests professional confidence in the Indrayani Biotech Ltd stock.